Profiles of Drug Substances, Excipients and Related Methodology, Volume 36

1. Buclizine

Gamal A. E. Mostafa and Abdullah A. Al-Badr

2. Chitin

Nidal H. Daraghmeh, Babur Z. Chowdhry, Stephen A. Leharne, Mahmoud M. Al Omari and Adnan A. Badwan

3. EZETIMIBE

Maria L.A.D Lestari, Febri Ardiana and Gunawan Indrayanto

4. Gemifloxacin

Badraddin M.H. Al-Hadiya1 and Ashraf M.M. Mahmoud

5. Glimepiride

Maria L.A.D Lestari and Gunawan Indrayanto

6. Lornoxicam

Mahrous O. Ahmed, Abdullah A. Al-Badr

7. Magnesium Silicate

Iyad Rashid, Nidal H. Daraghmeh, Mahmoud M. Al Omari, Babur Z. Chowdhry, Stephen A. Leharne , Hamdallah A. Hodali and Adnan A. Badwan

8. Tadalafil

Alaa A.-M. Abdel-Aziz, Yousif A. Asiri, Adel S. El-Azab, Mohamed A. Al-Omar and Takehisa Kunieda

9. Direct Crystallization of Enantiomers and Dissociable Diastereomers

Harry G. Brittain

10. Cocrystal Systems of Pharmaceutical Interest: 2009

Harry G. Brittain

Volumes in this widely revered series present comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. This organizational structure meets the needs of the pharmaceutical community and allows for the development of a timely vehicle for publishing review materials on this topic.

The scope of the Profiles series encompasses review articles and database compilations that fall within one of the following six broad categories: Physical profiles of drug substances and excipients; Analytical profiles of drug substances and excipients; Drug metabolism and pharmacokinetic profiles of drug substances and excipients; Methodology related to the characterization of drug substances and excipients; Methods of chemical synthesis; and Reviews of the uses and applications for individual drug substances, classes of drug substances, or excipients.

• Presents comprehensive reviews covering all aspects of drug development and formulation of drugs
• Profiles creatine monohydrate and fexofenadine hydrochloride, as well as five others
• Meets the information needs of the drug development community

Medicinal, pharmaceutical, and analytical chemists; pharmacologists